ScholarIQanswers from OpenAlex

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

PaperCitations, authors & open-access status

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) have?

ScholarIQcitation count

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) has 51 citations in the OpenAlex counts ScholarIQ stores.

When was Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) published?

ScholarIQyear

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) has 2014 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

ScholarIQoa status

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) has green oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

ScholarIQdoi

The DOI for Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) is on the source record.

Open the DOI →

What is the PMID of Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

ScholarIQpmid

The PMID for Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) is on the source record.

Open the PMID →

What is the OpenAlex record for Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

ScholarIQopenalex

The OpenAlex for Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) is on the source record.

Open the OpenAlex →

Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

How many citations does Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) have?

When was Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) published?

What is the open-access status of Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

What is the DOI of Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

What is the PMID of Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

What is the OpenAlex record for Outcomes of Eyes with Lesions Composed of &gt;50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)?

Related on ScholarIQ